Personalized Medicine for Diabetes
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Personalized medicine is an emerging concept for treating diseases, which involves determining specific information about a particular patient and then prescribing a treatment that is specific for that patient.1 Personalized medicine represents an approach for defining disease subtypes and defining biomarkers that can identify patients who are most likely to benefit from a specific treatment and other patients who are unlikely to respond or likely to experience side events. Not every patient with diabetes with the same age, duration of disease, body mass index, and Hemoglobin A1c will respond the same way to a given treatment. Some patients respond to a treatment whereas others do not. The reason may be a genetic propensity to respond or not respond to a drug. The physician must assess every patient and then attempt to guess which treatment will work best. If the physician could be armed with specific personalized information about that patient, including information about their genetic makeup, then treatments could be tailored for each individual patient. This approach would then lead to better outcomes without wasting time on ineffective therapy. Outcome statistics, which indicate that a certain percentage of patients will respond to a specific treatment, are not always meaningful for a given individual. For some diseases and treatments if one treatment is used, then 100% will respond and if another treatment is used then 0% will respond and for other patients a different treatment might be 100% effective. The problem is that physicians do not know which treatment is likely to be effective in any given patient, so the treatment that works most often for the greatest number of patients is usually selected first, even though this treatment will not be effective for some patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825
Inflammatory Process in Type 2 Diabetes: The Role of Cytokines
ALEXANDRAKI, K., PIPERI, C., KALOFOUTIS, C., SINGH, J., ALAVERAS, A., & KALOFOUTIS, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1372.039 · Cited by 309
Accuracy and predictive value of classification schemes for ketosis-prone diabetes
Balasubramanyam, A., Garza, G., Rodriguez, L., Hampe, C. S., Gaur, L., Lernmark, A., & Maldonado, M. R. (2006) · Diabetes Care · doi:10.2337/dc06-0749 · Cited by 166
Cited by
Asynchronous and synchronous teleconsultation for diabetes care: A systematic literature review
Verhoeven, F., Tanja-Dijkstra, K., Nijland, N., Eysenbach, G., & van Gemert-Pijnen, L. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400323 · Cited by 247
Janapala, R. N., Jayaraj, J. S., Fathima, N., Kashif, T., Usman, N., Dasari, A., Jahan, N., & Sachmechi, I. (2019) · Cureus · doi:10.7759/cureus.5634 · Cited by 117
Alharbi, A. A., Shaqran, T. M., Eltobgy, A. A. E., Albalawi, A. R., & Alnawmasi, W. S. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.322 · Cited by 5
Metadata
- Authors
- Klonoff, D. C.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2008-05
- Volume
- 2
- Issue
- 3
- Pages
- 335-341
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W1967880623
- Cited by
- 60
- References
- 3
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Personalized Medicine for Diabetes. https://app.cochat.ai/papers/10.1177/193229680800200301
- The paper
- Klonoff, D. C. (2008). Personalized Medicine for Diabetes. Journal of Diabetes Science and Technology. https://doi.org/10.1177/193229680800200301
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.